Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.

Trial Profile

Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2011

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2010 Results presented at the 30th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 05 May 2009 Planned end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 05 May 2009 Actual patient number (56) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top